Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 14 of 14 publications.

Ko DT, Khan AM, Kotrri G, Austin PC, Wijeysundera HC, Koh M, Chu A, Jackevicius CA, Lawler PR, Tu JV. Eligibility, clinical outcomes, and budget impact of PCSK9 inhibitor adoption: the CANHEART PCSK9 study. J Am Heart Assoc. 2018 Nov 6;7(21):e010007. doi: 10.1161/JAHA.118.010007

Sussman G, Abuzakouk M, Berard F, Canonica W, Oude Elberink H, Gimenez-Arnau A, Grattan C, Hollis K, Hunter S, Knulst A, Lacour JP, Lynde C, Marsland A, Mcbride D, Maurer M, Nakonechna A, Ortiz De Frutos J, Reynolds M, Sweeney C, Tian H, Weller K, Wolin D, Balp MM. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU. Allergy. 2018 Aug;73(8):1724-34. doi: 10.1111/all.13430

Martell B, DiBenedetti DB, Weiss H, Zhou X, Reynolds M, Berghella V, Hassan SS. Screening and treatment for short cervical length in pregnancy: a physician survey in the United States. Arch Gynecol Obstet. 2018 Mar;297(3):601-11. doi: 10.1007/s00404-017-4619-y

Maurer M, Abuzakouk M, Berard F, Canonica W, Oude Elberink H, Gimenez-Arnau A, Grattan C, Hollis K, Knulst A, Lacour JP, Lynde C, Marsland A, Mcbride D, Nakonechna A, Ortiz De Frutos J, Proctor C, Sussman G, Sweeney C, Tian H, Weller K, Wolin D, Balp M-M. The burden of chronic spontaneous urticaria is substantial: real-world evidence from ASSURE-CSU. Allergy. 2017 Dec;27(12):2005-16. doi: 10.1111/all.13209

Surrey E, Carter CM, Soliman AM, Khan S, DiBenedetti DB, Snabes MC. Patient-completed or symptom-based screening tools for endometriosis: a scoping review. Arch Gynecol Obstet. 2017 Aug;296(2):153-65. doi: 10.1007/s00404-017-4406-9

Maurer M, Weller K, Nakonechna A, Abouzakouk M, Hollis KA, McBride DW, Georgiou P, Balp MM, Grattan C. The first international study assessing the economic and humanistic burden of refractory chronic spontaneous/idiopathic urticaria: aSSURE-CSU. Poster presented at the European Academy of Allergy and Clinical Immunology Congress; August 2014. Copenhagen, Denmark. [abstract] Allergy. 2014 Sep; 69(Suppl 99):122.

Patorno E, Glynn RJ, Hernandez-Diaz S, Avorn J, Wahl PM, Bohn RL, Mines D, Liu J, Schneeweiss S. Risk of ischemic cerebrovascular and coronary events in adult users of anticonvulsant medications in routine care settings. J Am Heart Assoc. 2013 Jul 30;2(4):e000208. doi: 10.1161/JAHA.113.000208.

Heyes A, Lebiecki J, Serup-Hansen N, Andreasen J. Identification of cost-drivers in the management of patients with allergic rhinitis. Poster presented at the XXXI Congress of the European Academy of Allergy and Clinical Immunology; June 2012. Geneva, Switzerland. [abstract] Allergy. 2012 Nov; 67(S96):344.

Coon CD, Bokowy KL, Horblyuk R, Zisman RS, McLeod LD, Brown MT. The development and initial assessment of the strategy and leadership systems capability evaluation survey. Health Care Manag (Frederick). 2012 Oct 1;31(4):332-41.

Anto JM, Sunyer J, Basagana X, Garcia‐Esteban R, Cerveri I, de Marco R, Heinrich J, Janson C, Jarvis D, Kogevinas M, Kuenzli N, Leynaert B, Svanes C, Wjst M, Gislason T, Burney P. Risk factors of new-onset asthma in adults: a population-based international cohort study. Allergy. 2010 Aug;65(8):1021-30. doi: 10.1111/j.1398-9995.2009.02301.x

Arellano FM, Arana A, Wentworth CE. Potent topical steroids are the treatment for cutaneous T-cell lymphoma. Allergy. 2010;126(2):414-5.

Philpot E, Prillaman B, Wu W, Toler W. Correlation of patient-rated nasal congestion with peak nasal inspiratory flow assessments in three allergic rhinitis studies of fluticasone furoate nasal spray. Poster presented at the XXVIII EAACI Congress of the European Academy of Allergy and Clinical Immunology; June 2009. Warszawa, Poland. [abstract] Allergy. 2009; 64(S90):37-8.

Sunyer J, Pekkanen J, Garcia-Esteban R, Svanes C, Kunzli N, Janson C, de Marco R, Anto JM, Burney P. Asthma score: predictive ability and risk factors. Allergy. 2007 Feb;62(2):142-8. doi: 10.1111/j.1398-9995.2006.01184.x